Sialylation as a checkpoint for inflammatory and complement-related retinal diseases
Sialylation is a modification process involving the addition of sialic acid residues to the termini of glycoproteins and glycolipids in mammalian cells. Sialylation serves as a crucial checkpoint inhibitor of the complement and immune systems, particularly within the central nervous system (CNS), in...
Saved in:
| Main Authors: | Yiduo Min, German Cuevas-Rios, Thomas Langmann, Harald Neumann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cellular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2025.1623755/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina
by: Marcus Karlstetter, et al.
Published: (2016-12-01) -
Sialic Acids in Health and Disease
by: Gerardo N. Guerrero-Flores, et al.
Published: (2025-03-01) -
Role of Sialic Acids in Central Nervous System Immune Response
by: Karolina Narejko, et al.
Published: (2025-06-01) -
Chemical and Enzymatic Synthesis of DisialylGb5 and Other Sialosides for Glycan Array Assembly and Evaluation of Siglec-Mediated Immune Checkpoint Inhibition
by: Kuo-Shiang Liao, et al.
Published: (2025-05-01) -
Bacterial Sialidases: Biological Significance and Application
by: Stephan Engibarov, et al.
Published: (2025-04-01)